Vaxcyte, Inc. (PCVX) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Vaxcyte, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:04.410 Good afternoon, everyone. My name is Beau, and I will be your conference operator today. 00:00:04.410 -- 00:00:08.852 At this time, I would like to welcome everyone to the Backsite Fourth Quarter and Full 00:00:08.852 -- 00:00:12.273 Year 2023 Financial Results Conference Call. 00:00:12.273 -- 00:00:15.234 All lines have been placed on mute to prevent any background noise. 00:00:15.234 -- 00:00:18.735 After the speaker's remarks, there will be a question and answer period. 00:00:18.735 -- 00:00:22.516 If you would like to ask a question during this time, simply press star followed by the 00:00:22.516 -- 00:00:26.838 number one on your telephone keypad. If you would like to withdraw your question, simply 00:00:26.838 -- 00:00:31.640 press star two. And just a reminder, today's call is being recorded. 00:00:31.640 -- 00:00:33.400 Now at this time, I'll turn things over to Mr. 00:00:33.400 -- 00:00:37.141 Andrew Guggenheim, President and Chief Financial Officer of Backsite. 00:00:37.141 -- 00:00:39.722 Please go ahead, sir. 00:00:40.122 -- 00:00:43.203 Thank you, Operator, and good afternoon, everyone. 00:00:43.203 -- 00:00:48.625 I'd like to welcome you to Backsite's earnings conference call to discuss our 2023 results 00:00:48.625 -- 00:00:54.054 and to provide a business update. I'm joined today by our Chief Executive Officer, 00:00:54.054 -- 00:00:59.156 Grant Pickering, and our Executive Vice President and Chief Operating Officer, Jim 00:00:59.156 -- 00:01:00.857 Wassel. 00:01:00.857 -- 00:01:05.220 Earlier this afternoon, we issued a news release announcing our results. 00:01:05.220 -- 00:01:10.562 Copies of this and our other news releases, with its corporate presentation and SEC 00:01:10.562 -- 00:01:15.705 filings, can be fou...